CEO sold ~$44K of KRYS shares in the open market

Past results only. Not a forecast.

Record ID

0001298709-25-000013

Filed / recorded

Dec 5, 2025, 11:53 PM UTC

Added to OQRO

Oct 6, 2026, 7:59 PM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

Krystal Biotech, Inc.

Issuer CIK

1711279

Ticker

KRYS

Reporting person

Krish S Krishnan

Relationship

Director, Officer, 10% owner

Officer title

President and CEO

Security

Common Stock

Table

Non-derivative (Table I)

Transaction date

Dec 4, 2025

Transaction code

S

Shares / units

200

Price per share

$222.38

Acquired / disposed

Disposed (D)

Shares owned after

1,413,711

Ownership form

Indirect — By Spouse

Amendment

No

1. The sales reported were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person's spouse, Suma M. Krishnan, on September 4, 2025. The Rule 10b5-1 trading plan started on December 4, 2025 and will terminate on December 4, 2026, or earlier upon completion of the sale of the maximum number of shares of Common Stock subject to the Rule 10b5-1 trading plan.
2. The transaction was executed in multiple trades ranging from $222.34 to $222.41. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
3. Directly beneficially owned by Suma M. Krishnan, the spouse of the Reporting Person.